SMT201700347T1 - Modulatori di ror-gamma-t chinolinilici legati a metilene - Google Patents

Modulatori di ror-gamma-t chinolinilici legati a metilene

Info

Publication number: SMT201700347T1
Authority: SM; San Marino
Prior art keywords: ror; modulators; gamma; methylene; linked quinolinyl
Prior art date: 2012-10-16

Application number

SM20170347T

Other languages

English (en)

Inventor

Steven Goldberg

Kristi A Leonard

Kent Barbay

James P Edwards

Kevin D Kreutter

David A Kummer

Umar Maharoof

Rachel Nishimura

Maud Urbanski

Hariharan Venkatesan

Aihua Wang

Ronald L Wolin

Craig R Woods

Joan Pierce

Anne Fourie

Xiaohua Xue

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-16

Filing date

2013-10-15

Publication date

2017-09-07

2013-10-15 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2017-09-07 Publication of SMT201700347T1 publication Critical patent/SMT201700347T1/it

Links

-1 QUINOLINYL Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)

SM20170347T 2012-10-16 2013-10-15 Modulatori di ror-gamma-t chinolinilici legati a metilene SMT201700347T1 (it)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US201261714419P	2012-10-16	2012-10-16
US201261725528P	2012-11-13	2012-11-13
US201361782257P	2013-03-14	2013-03-14
EP13786564.8A EP2909192B1 (en)	2012-10-16	2013-10-15	Methylene linked quinolinyl modulators of ror-gamma-t
PCT/US2013/065013 WO2014062658A1 (en)	2012-10-16	2013-10-15	Methylene linked quinolinyl modulators of ror-gamma-t

Publications (1)

Publication Number	Publication Date
SMT201700347T1 true SMT201700347T1 (it)	2017-09-07

Family

ID=49546611

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM20170347T SMT201700347T1 (it)	2012-10-16	2013-10-15	Modulatori di ror-gamma-t chinolinilici legati a metilene

Country Status (38)

Country	Link
US (1)	US9290476B2 (it)
EP (1)	EP2909192B1 (it)
JP (1)	JP6466335B2 (it)
KR (1)	KR20150070347A (it)
CN (1)	CN105209453B (it)
AR (1)	AR093017A1 (it)
AU (1)	AU2013331496B2 (it)
BR (1)	BR112015008308A2 (it)
CA (1)	CA2888210C (it)
CL (1)	CL2015000945A1 (it)
CR (1)	CR20150193A (it)
CY (1)	CY1119234T1 (it)
DK (1)	DK2909192T3 (it)
EA (1)	EA026415B1 (it)
EC (1)	ECSP15015022A (it)
ES (1)	ES2632269T3 (it)
GT (1)	GT201500093A (it)
HR (1)	HRP20171082T1 (it)
HU (1)	HUE035335T2 (it)
IL (1)	IL237866B (it)
LT (1)	LT2909192T (it)
ME (1)	ME02794B (it)
MX (1)	MX358508B (it)
MY (1)	MY189505A (it)
NI (1)	NI201500053A (it)
NZ (1)	NZ706775A (it)
PE (1)	PE20150778A1 (it)
PH (1)	PH12015500817B1 (it)
PL (1)	PL2909192T3 (it)
PT (1)	PT2909192T (it)
RS (1)	RS56283B1 (it)
SG (1)	SG11201502369XA (it)
SI (1)	SI2909192T1 (it)
SM (1)	SMT201700347T1 (it)
TW (1)	TWI606045B (it)
UY (1)	UY35084A (it)
WO (1)	WO2014062658A1 (it)
ZA (1)	ZA201503418B (it)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013120771A1 (en) *	2012-02-13	2013-08-22	F. Hoffmann-La Roche Ag	Imidazolylketone derivatives asd aldosterone synthase inhibitors
AU2013403335B2 (en) *	2012-10-16	2018-11-15	Janssen Pharmaceutica Nv	Methylene linked quinolinyl modulators of ROR-gamma-t
US9604982B2 (en)	2013-03-14	2017-03-28	Janssen Pharmaceutica Nv	P2X7 modulators
US9040534B2 (en)	2013-03-14	2015-05-26	Janssen Pharmaceutica Nv	[1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators
ES2845473T3 (es)	2013-03-14	2021-07-26	Boehringer Ingelheim Int	(Bencil-ciano-metil)-amidas sustituidas de ácido 2-aza-biciclo[2.2.1]heptano-3-carboxílico inhibidores de la catepsina- C
JO3509B1 (ar)	2013-03-14	2020-07-05	Janssen Pharmaceutica Nv	معدلات p2x7
TWI644671B (zh)	2013-03-14	2018-12-21	比利時商健生藥品公司	Ｐ２ｘ７調節劑
JP6407285B2 (ja)	2013-09-09	2018-10-17	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	ＲＯＲγ調節因子
US9284308B2 (en) *	2013-10-15	2016-03-15	Janssen Pharmaceutica Nv	Methylene linked quinolinyl modulators of RORγt
US10555941B2 (en) *	2013-10-15	2020-02-11	Janssen Pharmaceutica Nv	Alkyl linked quinolinyl modulators of RORγt
US9403816B2 (en)	2013-10-15	2016-08-02	Janssen Pharmaceutica Nv	Phenyl linked quinolinyl modulators of RORγt
BR112016008215A2 (pt)	2013-10-15	2017-09-26	Janssen Pharmaceutica Nv	moduladores de quinolinila ligados por alquila de roryt
BR112016008258A2 (pt)	2013-10-15	2017-10-10	Janssen Pharmaceutica Nv	moduladores de ror?t de quinolinila
JP6320523B2 (ja) *	2013-10-15	2018-05-09	ヤンセンファーマシューティカエヌ．ベー．	ＲＯＲγＴの第二級アルコールキノリニルモジュレータ
ES2716966T3 (es) *	2014-05-28	2019-06-18	Glaxosmithkline Ip Dev Ltd	Derivados de piperazina como moduladores de ROR-gamma
EP3180335B1 (en)	2014-08-11	2021-05-05	Angion Biomedica Corporation	Cytochrome p450 inhibitors and uses thereof
EP3511331A1 (en)	2014-09-12	2019-07-17	Boehringer Ingelheim International GmbH	Spirocyclic inhibitors of cathepsin c
AU2015315693B2 (en)	2014-09-12	2020-01-16	Janssen Pharmaceutica Nv	P2X7 modulating n-acyl-triazolopyrazines
WO2016039977A1 (en)	2014-09-12	2016-03-17	Janssen Pharmaceutica Nv	P2x7 modulators
CA2970819A1 (en)	2014-12-31	2016-07-07	Angion Biomedica Corp.	Methods and agents for treating disease
KR20210069079A (ko)	2018-09-28	2021-06-10	얀센 파마슈티카 엔.브이.	모노아실글리세롤 리파아제 조절제
MY205440A (en)	2018-09-28	2024-10-21	Janssen Pharmaceutica Nv	Monoacylglycerol lipase modulators
US10947253B2 (en)	2019-08-05	2021-03-16	Ankh Life Sciences Limited	Fused polycyclic dimers
JP7697934B2 (ja)	2019-09-30	2025-06-24	ヤンセンファーマシューティカエヌ．ベー．	放射線標識されたｍｇｌｐｅｔリガンド
KR20220093340A (ko) *	2019-10-31	2022-07-05	지앙수 헨그루이 메디슨 컴퍼니 리미티드	RORγ 조절제의 산부가염
BR112022019077A2 (pt)	2020-03-26	2022-12-27	Janssen Pharmaceutica Nv	Moduladores da monoacilglicerol lipase
AU2021266148A1 (en)	2020-04-30	2023-01-05	Idorsia Pharmaceuticals Ltd	Azetidin-3-ylmethanol derivatives as CCR6 receptor modulators
US12129265B2 (en)	2020-07-21	2024-10-29	Ankh Life Sciences Limited	Therapeutic agents and uses thereof
CN112939974B (zh) *	2021-03-11	2023-10-20	中山大学	一种氮杂苯并薁衍生物的制备方法
WO2023057548A1 (en)	2021-10-07	2023-04-13	Idorsia Pharmaceuticals Ltd	Ccr6 receptor modulators
WO2023072924A1 (en)	2021-10-26	2023-05-04	Idorsia Pharmaceuticals Ltd	Ccr6 receptor modulators
TW202325271A (zh)	2021-10-28	2023-07-01	瑞士商愛杜西亞製藥有限公司	Ccr6受體調節劑

Family Cites Families (102)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3472859A (en)	1966-11-01	1969-10-14	Sterling Drug Inc	1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
JPS4826772Y1 (it)	1969-04-04	1973-08-06
ATE27451T1 (de)	1981-03-24	1987-06-15	Ciba Geigy Ag	Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
US4910327A (en)	1982-05-25	1990-03-20	American Cyanamid Company	Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid: dialkyl 3-(substituted)phenylaminobut-2-ene-dioates and methods for the preparation thereof
US4656283A (en)	1982-05-25	1987-04-07	American Cyanamid Company	Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid
US4710507A (en)	1983-12-22	1987-12-01	Pfizer Inc.	Quinolone inotropic agents
FR2634483B2 (fr)	1987-12-29	1994-03-04	Esteve Labor Dr	Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
CA2002864C (en)	1988-11-29	1999-11-16	Eddy J. E. Freyne	(1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
SG64322A1 (en)	1991-05-10	1999-04-27	Rhone Poulenc Rorer Int	Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
US5478832A (en)	1992-05-08	1995-12-26	The Green Cross Corporation	Quinoline compounds
JPH0826772A (ja)	1994-07-22	1996-01-30	Sony Corp	融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法
DE69512495T2 (de)	1994-10-27	2000-02-03	Asahi Glass Co. Ltd., Tokio/Tokyo	Verfahren zur Herstellung von Chinolin-2-yl-benzoesäure
GB9523267D0 (en)	1995-11-14	1996-01-17	Sandoz Ltd	Organic compounds
SK283335B6 (sk)	1995-12-08	2003-06-03	Janssen Pharmaceutica N. V.	(Imidazol-5-yl)metyl-2-chinolinónové deriváty, spôsob a medziprodukty na ich prípravu, ich použitie a farmaceutické kompozície na ich báze
AU710926B2 (en)	1996-05-20	1999-09-30	Merck & Co., Inc.	Antagonists of gonadotropin releasing hormone
AU740603B2 (en) *	1997-06-02	2001-11-08	Janssen Pharmaceutica N.V.	(imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
PL341364A1 (en)	1997-12-22	2001-04-09	Upjohn Co	4-hydroxyqinoline-3-carboxamides and hydrazides as antiviral agents
FR2776388B1 (fr)	1998-03-20	2006-04-28	Lipha	Utilisation de recepteurs de la famille ror pour le criblage de substances utiles pour le traitement de l'atherosclerose
US6399629B1 (en)	1998-06-01	2002-06-04	Microcide Pharmaceuticals, Inc.	Efflux pump inhibitors
HRP20000904A2 (en) *	1998-07-06	2001-12-31	Janssen Pharmaceutica Nv	Farnesyl protein transferase inhibitors for treating arthropathies
ID26987A (id)	1998-07-06	2001-02-22	Janssen Pharmaceutica Nv	Inhibitor-inhibitor transferase protein farnesil dengan sifat-sifat peka terhadap sinar radiasi in vivo
JP2000169451A (ja)	1998-09-30	2000-06-20	Kyorin Pharmaceut Co Ltd	６，７―ジ置換キノリンカルボン酸誘導体とその付加塩及びそれらの製造方法
ID29241A (id)	1998-12-23	2001-08-16	Janssen Pharmaceutica Nv	Turunan-turunan kinolin teranelasi-1,2
US6248736B1 (en)	1999-01-08	2001-06-19	Pharmacia & Upjohn Company	4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
US6248739B1 (en)	1999-01-08	2001-06-19	Pharmacia & Upjohn Company	Quinolinecarboxamides as antiviral agents
PL349839A1 (en)	1999-02-11	2002-09-23	Pfizer Prod Inc	Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
PT1106612E (pt)	1999-11-30	2004-06-30	Pfizer Prod Inc	Derivados de quinolina uteis para inibir a farnesil-proteina-transferase
JP5491681B2 (ja)	2000-02-04	2014-05-14	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	乳ガンの治療のためのファルネシルタンパク質トランスフェラーゼ阻害剤
US6838467B2 (en)	2000-02-24	2005-01-04	Janssen Pharmaceutica N. V.	Dosing regimen
AU2001244167A1 (en)	2000-02-29	2001-09-12	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
JP2003525252A (ja)	2000-02-29	2003-08-26	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｈｅｒ２抗体とのファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤
WO2001064196A2 (en)	2000-02-29	2001-09-07	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitor combinations with vinca alkaloids
AU2001252147A1 (en)	2000-02-29	2001-09-12	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitor combinations
EP1261343A2 (en)	2000-02-29	2002-12-04	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
US20030027808A1 (en)	2000-02-29	2003-02-06	Palmer Peter Albert	Farnesyl protein transferase inhibitor combinations with platinum compounds
US20030078281A1 (en)	2000-02-29	2003-04-24	Rybak Mary Ellen Margaret	Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents
JP2003525239A (ja)	2000-02-29	2003-08-26	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	タキサン化合物とのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤
CA2397448A1 (en)	2000-02-29	2001-09-07	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitor combinations with further anti-cancer agents
EP1267871A2 (en)	2000-02-29	2003-01-02	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
WO2001064194A2 (en)	2000-02-29	2001-09-07	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitor combinations with camptothecin compounds
US6844357B2 (en)	2000-05-01	2005-01-18	Pfizer Inc.	Substituted quinolin-2-one derivatives useful as antiproliferative agents
US6525049B2 (en)	2000-07-05	2003-02-25	Pharmacia & Upjohn Company	Pyrroloquinolones as antiviral agents
US6624159B2 (en)	2000-07-12	2003-09-23	Pharmacia & Upjohn Company	Heterocycle carboxamides as antiviral agents
ATE276262T1 (de)	2000-07-12	2004-10-15	Upjohn Co	Oxazinochinolone für die behandlung viraler infektionen
WO2002024682A1 (en)	2000-09-25	2002-03-28	Janssen Pharmaceutica N.V.	Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
WO2002024686A2 (en)	2000-09-25	2002-03-28	Janssen Pharmaceutica N.V.	Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
US7067531B2 (en)	2000-09-25	2006-06-27	Angibaud Patrick Rene	Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
CZ20031145A3 (cs)	2000-10-02	2003-12-17	Janssen Pharmaceutica N.V.	Antagonisté metabotropního glutamátového receptoru
DK1339407T3 (da)	2000-11-28	2006-08-14	Janssen Pharmaceutica Nv	Farnesylproteintransferaseinhibitorer til behandling af inflammatorisk tarmsygdom
ES2260316T3 (es)	2000-12-27	2006-11-01	Janssen Pharmaceutica N.V.	Derivados de quinazolina y quinolina 4-sustituidos que inhiben la farnesil transferasa.
JP4969016B2 (ja)	2001-02-15	2012-07-04	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	抗エストロゲン剤とファルネシルプロテイントランスフェラーゼ阻害剤の組み合わせ物
US6544990B2 (en)	2001-03-01	2003-04-08	Pharmacia & Upjohn Company	Substituted quinolinecarboxamides as antiviral agents
EP1390033A1 (en)	2001-04-25	2004-02-25	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitors for treating cachexia
EP1412367A4 (en)	2001-06-21	2006-05-03	Ariad Pharma Inc	NEW CHINOLINE AND ITS USE
EP1456208A1 (en)	2001-12-20	2004-09-15	PHARMACIA & UPJOHN COMPANY	Pyridoquinoxaline antivirals
AU2002350244A1 (en)	2001-12-20	2003-07-09	Pharmacia And Upjohn Company	Pyridoquinoxaline antivirals
CA2479109C (en)	2002-03-29	2011-08-02	Janssen Pharmaceutica N.V.	Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
ATE404537T1 (de)	2002-08-13	2008-08-15	Shionogi & Co	Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
AU2003262947A1 (en)	2002-08-30	2004-03-19	Pharmacia And Upjohn Company	Method of preventing or treating atherosclerosis or restenosis
GB0222516D0 (en)	2002-09-27	2002-11-06	Karobio Ab	Novel compounds
RS20060018A (sr)	2003-07-14	2007-12-31	Arena Pharmaceuticals Inc.,	Derivati spojenih arila i heteroarila kao modulatori metabolizma u profilaksi i lečenju sa njima povezanih stanja
BRPI0416206A (pt)	2003-11-20	2006-12-26	Janssen Pharmaceutica Nv	2-quinolinonas e 2-quinoxalinonas substituìdas por 6-alquenila e 6-fenilalquila como inibidores de polimerase de poli(adp-ribose)
SG151249A1 (en)	2003-12-05	2009-04-30	Janssen Pharmaceutica Nv	6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
US7652014B2 (en)	2003-12-10	2010-01-26	Janssen Pharmaceutica	Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
AU2004298486A1 (en)	2003-12-12	2005-06-30	Wyeth	Quinolines useful in treating cardiovascular disease
EA011277B1 (ru)	2004-01-23	2009-02-27	Янссен Фармацевтика Н.В.	Производные хинолина и их применение в качестве ингибиторов микобактерий
EA011572B9 (ru)	2004-01-29	2018-01-31	Янссен Фармацевтика Н.В.	Производные хинолина для применения в качестве микобактериальных ингибиторов
JP2005225250A (ja)	2004-02-10	2005-08-25	Murakami Corp	車載用監視装置
ATE540936T1 (de)	2004-06-30	2012-01-15	Janssen Pharmaceutica Nv	Substituierte 2-alkyl-chinazolinonderivate als parp-hemmer
ES2407813T3 (es)	2004-08-04	2013-06-14	Meiji Seika Pharma Co., Ltd.	Derivados de quinolina e insecticida que contienen los mismos como constituyente activo
KR100686531B1 (ko)	2004-08-31	2007-02-23	한국화학연구원	히스톤 디아세틸라제 저해활성을 갖는 아릴아미노메틸프로페닐 벤즈하이드록시아마이드 유도체 및 그의 제조방법
HRP20130399T1 (hr)	2004-11-05	2013-06-30	Janssen Pharmaceutica Nv	Terapeutska upotreba inhibitora farenziltransferaze i postupci praä†enja njihove efikasnosti
JO2855B1 (en)	2005-08-03	2015-03-15	شركة جانسين فارماسوتيكا ان. في	Quinoline derivatives acting as antibacterial agents
JO2952B1 (en)	2005-08-03	2016-03-15	جانسين فارماسوتيكا ان. في	Quinoline derivatives acting as antibacterial agents
WO2007088978A1 (ja)	2006-02-03	2007-08-09	Meiji Seika Kaisha, Ltd.	新規キノリン誘導体およびこれを有効成分として含有する農園芸用殺菌剤
US8389739B1 (en)	2006-10-05	2013-03-05	Orphagen Pharmaceuticals	Modulators of retinoid-related orphan receptor gamma
KR101083177B1 (ko)	2006-10-23	2011-11-11	에스지엑스 파마슈티컬스, 인코포레이티드	트리아졸로-피리다진 단백질 키나제 조정제
JO3271B1 (ar)	2006-12-06	2018-09-16	Janssen Pharmaceutica Nv	مشتقات الكوينولين المضادة للجراثيم
AR065093A1 (es)	2007-02-05	2009-05-13	Merck Frosst Canada Ltd	Compuestos farmacéuticos inhibidores de la biosintesis de leucotrienos
UY30892A1 (es)	2007-02-07	2008-09-02	Smithkline Beckman Corp	Inhibidores de la actividad akt
EP2155197A4 (en)	2007-03-09	2011-10-12	Link Medicine Corp	TREATMENT OF LYSOSOMAL STORAGE DISEASES
EP2162132A4 (en)	2007-05-21	2013-01-16	Sgx Pharmaceuticals Inc	Heterocyclic kinase modulators
CN101143845B (zh)	2007-10-15	2010-08-25	中国药科大学	取代喹啉甲酰胍衍生物、其制备方法及其医药用途
AU2009205539B2 (en)	2008-01-18	2013-12-05	Allergan.Inc	Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
JP2011511056A (ja)	2008-02-05	2011-04-07	ファイザー・インク	Ｃｎｓ障害および代謝障害治療のためのピリジニルアミド
BRPI0912604A2 (pt)	2008-05-13	2019-09-10	Allergan Inc	quinolinilmetilimidazóis como agentes terapêuticos
WO2010068296A1 (en)	2008-12-11	2010-06-17	Stiefel Laboratories, Inc.	Piperazine carboxamidines as antimicrobial agents
WO2010127208A1 (en)	2009-04-30	2010-11-04	Forest Laboratories Holdings Limited	Inhibitors of acetyl-coa carboxylase
CN101899011B (zh)	2009-05-26	2013-01-16	北京大学	氨基二硫代甲酸酯类化合物、其制备方法和应用
AR077004A1 (es)	2009-06-09	2011-07-27	Hoffmann La Roche	Compuestos heterociclicos antivirales
SG176986A1 (en)	2009-06-25	2012-02-28	Amgen Inc	Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
CA2771432A1 (en)	2009-08-20	2011-02-24	Novartis Ag	Heterocyclic oxime compounds
EP2368886A1 (en)	2010-03-01	2011-09-28	Phenex Pharmaceuticals AG	Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
US9101600B2 (en)	2010-03-11	2015-08-11	New York University	Compounds as RORγt modulators and uses thereof
CN105962259A (zh)	2010-04-15	2016-09-28	卓莫赛尔公司	用于减小或消除苦味的化合物、组合物和方法
WO2012064744A2 (en) *	2010-11-08	2012-05-18	Lycera Corporation	Tetrahydroquinoline and related bicyclic compounds for inhibition of rorϒ activity and the treatment of disease
US11179500B2 (en)	2011-02-24	2021-11-23	Emory University	JAB1 inhibitory compositions for ossification and methods related thereto
PE20141637A1 (es)	2011-04-28	2014-11-20	Japan Tobacco Inc	Compuesto de amida y aplicacion farmaceutica para el mismo
WO2012158784A2 (en)	2011-05-16	2012-11-22	Theodore Mark Kamenecka	Modulators of the nuclear hormone receptor ror
GB201118652D0 (en)	2011-10-28	2011-12-07	Astex Therapeutics Ltd	New compounds
WO2013064231A1 (en)	2011-10-31	2013-05-10	Phenex Pharmaceuticals Ag	SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
EP2800745B1 (en)	2011-12-02	2020-02-12	Phenex Pharmaceuticals AG	Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases

2013
- 2013-10-15 US US14/053,653 patent/US9290476B2/en not_active Expired - Fee Related
- 2013-10-15 EA EA201590736A patent/EA026415B1/ru unknown
- 2013-10-15 RS RS20170741A patent/RS56283B1/sr unknown
- 2013-10-15 TW TW102137062A patent/TWI606045B/zh not_active IP Right Cessation
- 2013-10-15 AR ARP130103735A patent/AR093017A1/es unknown
- 2013-10-15 EP EP13786564.8A patent/EP2909192B1/en active Active
- 2013-10-15 CA CA2888210A patent/CA2888210C/en not_active Expired - Fee Related
- 2013-10-15 PT PT137865648T patent/PT2909192T/pt unknown
- 2013-10-15 WO PCT/US2013/065013 patent/WO2014062658A1/en not_active Ceased
- 2013-10-15 PE PE2015000491A patent/PE20150778A1/es active IP Right Grant
- 2013-10-15 ES ES13786564.8T patent/ES2632269T3/es active Active
- 2013-10-15 SG SG11201502369XA patent/SG11201502369XA/en unknown
- 2013-10-15 MX MX2015004783A patent/MX358508B/es active IP Right Grant
- 2013-10-15 HU HUE13786564A patent/HUE035335T2/en unknown
- 2013-10-15 SM SM20170347T patent/SMT201700347T1/it unknown
- 2013-10-15 AU AU2013331496A patent/AU2013331496B2/en not_active Ceased
- 2013-10-15 PL PL13786564T patent/PL2909192T3/pl unknown
- 2013-10-15 MY MYPI2015701186A patent/MY189505A/en unknown
- 2013-10-15 ME MEP-2017-151A patent/ME02794B/me unknown
- 2013-10-15 LT LTEP13786564.8T patent/LT2909192T/lt unknown
- 2013-10-15 JP JP2015537769A patent/JP6466335B2/ja not_active Expired - Fee Related
- 2013-10-15 HR HRP20171082TT patent/HRP20171082T1/hr unknown
- 2013-10-15 DK DK13786564.8T patent/DK2909192T3/en active
- 2013-10-15 KR KR1020157012838A patent/KR20150070347A/ko not_active Abandoned
- 2013-10-15 NZ NZ706775A patent/NZ706775A/en not_active IP Right Cessation
- 2013-10-15 SI SI201330702T patent/SI2909192T1/sl unknown
- 2013-10-15 BR BR112015008308A patent/BR112015008308A2/pt not_active Application Discontinuation
- 2013-10-15 CN CN201380065903.1A patent/CN105209453B/zh not_active Expired - Fee Related
- 2013-10-15 UY UY0001035084A patent/UY35084A/es unknown
2015
- 2015-03-22 IL IL237866A patent/IL237866B/en active IP Right Grant
- 2015-04-13 CR CR20150193A patent/CR20150193A/es unknown
- 2015-04-14 PH PH12015500817A patent/PH12015500817B1/en unknown
- 2015-04-15 CL CL2015000945A patent/CL2015000945A1/es unknown
- 2015-04-15 EC ECIEPI201515022A patent/ECSP15015022A/es unknown
- 2015-04-15 GT GT201500093A patent/GT201500093A/es unknown
- 2015-04-15 NI NI201500053A patent/NI201500053A/es unknown
- 2015-05-15 ZA ZA2015/03418A patent/ZA201503418B/en unknown
2017
- 2017-07-25 CY CY20171100793T patent/CY1119234T1/el unknown

Also Published As

Publication number	Publication date
MY189505A (en)	2022-02-16
CN105209453A (zh)	2015-12-30
US9290476B2 (en)	2016-03-22
EA026415B1 (ru)	2017-04-28
WO2014062658A1 (en)	2014-04-24
CR20150193A (es)	2015-05-18
NZ706775A (en)	2018-10-26
MX2015004783A (es)	2015-08-14
EP2909192B1 (en)	2017-05-17
SI2909192T1 (sl)	2017-08-31
DK2909192T3 (en)	2017-08-07
CN105209453B (zh)	2017-06-20
JP6466335B2 (ja)	2019-02-06
AU2013331496B2 (en)	2017-07-27
ES2632269T3 (es)	2017-09-12
HRP20171082T1 (hr)	2017-10-06
ECSP15015022A (es)	2016-01-29
RS56283B1 (sr)	2017-12-29
TWI606045B (zh)	2017-11-21
LT2909192T (lt)	2017-07-10
CL2015000945A1 (es)	2015-08-28
AR093017A1 (es)	2015-05-13
PH12015500817A1 (en)	2015-06-08
CA2888210C (en)	2021-02-09
PL2909192T3 (pl)	2017-09-29
ME02794B (me)	2018-01-20
HUE035335T2 (en)	2018-05-02
HK1213248A1 (en)	2016-06-30
PT2909192T (pt)	2017-08-04
AU2013331496A1 (en)	2015-04-09
CY1119234T1 (el)	2018-02-14
TW201427969A (zh)	2014-07-16
PE20150778A1 (es)	2015-05-23
BR112015008308A2 (pt)	2017-12-05
CA2888210A1 (en)	2014-04-24
US20140107094A1 (en)	2014-04-17
SG11201502369XA (en)	2015-05-28
NI201500053A (es)	2020-03-18
EA201590736A1 (ru)	2015-09-30
JP2015536320A (ja)	2015-12-21
UY35084A (es)	2014-04-30
GT201500093A (es)	2017-09-26
IL237866B (en)	2018-05-31
EP2909192A1 (en)	2015-08-26
WO2014062658A8 (en)	2014-07-10
ZA201503418B (en)	2017-11-29
PH12015500817B1 (en)	2015-06-08
KR20150070347A (ko)	2015-06-24
MX358508B (es)	2018-08-22

Publication	Publication Date	Title
NL301178I2 (nl)	2024-04-25	Pegcetacoplan
SMT201700347T1 (it)	2017-09-07	Modulatori di ror-gamma-t chinolinilici legati a metilene
BR302012005254S1 (pt)	2013-10-08	Configuracao aplicada a autoinjetor
DK2863961T3 (da)	2019-01-02	Hæmostatiske indretninger
BR302012006265S1 (pt)	2015-08-25	Configuração aplicada a recipiente
BR112014016855A2 (pt)	2017-06-13	soluções aglutinantes
EP2840102A4 (en)	2015-05-20	copolycarbonate
BR302012004946S1 (pt)	2015-08-11	Configuracao aplicada a recipiente
EP2853866A4 (en)	2016-01-20	PHOTO DETECTOR
BR302013001239S1 (pt)	2014-06-03	Configuração aplicada a caneta
BR302012006385S1 (pt)	2015-08-25	Configuração aplicada a recipiente
EP2863742A4 (en)	2016-03-30	MICRO CAPSULE
EP2853867A4 (en)	2016-01-20	PHOTO DETECTOR
DE112013005394A5 (de)	2015-08-13	Deckelfester Ausrücker
BR112015004345A2 (pt)	2017-07-04	cartão
ES1076984Y (es)	2012-08-20	Transportador de palots
BR302012006790S1 (pt)	2014-10-29	Configuração aplicada a liquidificador
BR302012005876S1 (pt)	2014-05-27	Configuração aplicada a liquidificador
BR302013000042S1 (pt)	2014-06-03	Configuração aplicada a recipiente
BR302012005180S1 (pt)	2014-06-17	Configuração aplicada a recipiente
UA24737S (uk)	2013-05-13	Трюмо
ES1078189Y (es)	2013-03-04	Torreta
UA25274S (uk)	2013-08-12	Етикетка
UA25117S (uk)	2013-07-10	Етикетка
UA24761S (uk)	2013-05-13	Етикетка